Literature DB >> 4974623

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.

R W Colman, L Mattler, S Sherry.   

Abstract

By measurement of its arginine esterase activity, plasma kallikrein was purified from fresh frozen ACD plasma. The steps involved alcohol fractionation, isoelectric precipitation, and carboxymethyl (CM) Sephadex and DEAE cellulose chromatography. Three enzymatically active fractions were finally isolated and termed plasma kallikreins I, II, and III; they represented purifications of 970,320- and 590-fold, respectively. All three kallikreins were active biologically; they increased vascular permeability in the guinea pig and released a kinin from human plasma, as measured in the rat uterus bioassay. Bradykinin and/or closely related kinins were identified in the kallikrein I plasma digest by radioimmunoassay. Kallikreins I, II, and III had similar ratios of hydrolytic activity on a variety of arginine and lysine esters and were immunochemically related. However, differences were present on physicochemical characterization: kallikrein I had S(20,[unk]) of 5.7, a mol wt of 99,800, and migrated as a slow gamma globulin; kallikrein II migrated as a fast gamma globulin with a mol wt of 163,000, but the evidence suggested that it was closely related, if not interconvertible, with kallikrein I. Kallikrein III, on the other hand, migrated as an alpha globulin and reacted quite differently with inhibitors.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4974623      PMCID: PMC322187          DOI: 10.1172/JCI105959

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  ASSAY OF UROKINASE PREPARATIONS WITH THE SYNTHETIC SUBSTRATE ACETYL-L-LYSINE METHYL ESTER.

Authors:  S SHERRY; N ALKJAERSIG; A P FLETCHER
Journal:  J Lab Clin Med       Date:  1964-07

2.  SIMPLIFIED "DISC" (POLYACRYLAMIDE GEL) ELECTROPHORESIS.

Authors:  J T CLARKE
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  Immunological properties of the kallikreins.

Authors:  M E WEBSTER; E W EMMART; W A TURNER; H MORIYA; J V PIERCE
Journal:  Biochem Pharmacol       Date:  1963-05       Impact factor: 5.858

4.  The nature of the kallidins released from human plasma by kallikreins and other enzymes.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

5.  Action of the kallikreins on synthetic ester substrates.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

6.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

7.  Measurement of the rate of plasmin action on synthetic substrates.

Authors:  P S ROBERTS
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

8.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

9.  Production of antibody against bradykinin: demonstration of specificity by complement fixation and radio-immunoassay.

Authors:  J Spragg; K F Austen; E Haber
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

10.  Observations on the spontaneous arginine and lysine esterase activity of human plasma, and their relation to Hageman factor.

Authors:  S Sherry; N K Alkjaersig; A P Fletcher
Journal:  Thromb Diath Haemorrh Suppl       Date:  1966
View more
  23 in total

1.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

2.  Investigation of the esterolytic activity of human blood plasma after treatment with kaolin and streptokinase.

Authors:  N V Komissarova; O A Gomazkov
Journal:  Bull Exp Biol Med       Date:  1974-08       Impact factor: 0.804

3.  Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

Authors:  P C Harpel; M W Mosesson
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

4.  On the endogenous mechanism of kinin release. I. Attempts at discriminating kallikreins.

Authors:  R Jahrreiss; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

Authors:  D Ogston; C M Ogston; O D Ratnoff; C D Forbes
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

6.  Studies of contact activation of blood in haemodialysis.

Authors:  E N Wardle; D A Piercy
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

7.  Studies on the prekallikrein-bradykininogen system in liver disease.

Authors:  D Stewart; L M Blendis; R Williams
Journal:  J Clin Pathol       Date:  1972-05       Impact factor: 3.411

8.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  Human plasma kallikrein. A rapid purification method with high yield.

Authors:  H Nagase; A J Barrett
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

10.  The isolation of human plasma prekallikrein.

Authors:  D J McConnell; B Mason
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.